Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met

Colon cancer prevention currently relies on colonoscopy using white light to detect and remove polyps, but small and flat polyps are difficult to detect and frequently missed when using this technique. Fluorescence colonoscopy combined with a fluorescent probe specific for a polyp biomarker may improve polyp detection. Here we describe GE-137, a water-soluble probe consisting of a 26–amino acid cyclic peptide that binds the human tyrosine kinase c-Met conjugated to a fluorescent cyanine dye. Intravenous administration of GE-137 leads to its accumulation specifically in c-Met–expressing tumors in mice, and it is safe and well tolerated in humans. Fluorescence colonoscopy in patients receiving intravenous GE-137 enabled visualization of all neoplastic polyps that were visible with white light (38), as well as an additional nine polyps that were not visible with white light. This first-in-human pilot study shows that molecular imaging using an intravenous fluorescent agent specific for c-Met is feasible and safe, and that it may enable the detection of polyps missed by other techniques.

[1]  N. S. van den Berg,et al.  Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC. , 2011, Translational oncology.

[2]  Markus F Neurath,et al.  Molecular imaging of VEGF in gastrointestinal cancer in vivo using confocal laser endomicroscopy , 2010, Gut.

[3]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[4]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[5]  B. Nordlinger,et al.  Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[7]  B. Mayinger,et al.  Hexaminolevulinate-induced fluorescence colonoscopy versus white light endoscopy for diagnosis of neoplastic lesions in the colon. , 2010, Endoscopy.

[8]  K. Devarajan,et al.  Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity. , 2011, Neoplasia.

[9]  V J Wielenga,et al.  Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. , 2000, The American journal of pathology.

[10]  Tessa Buckle,et al.  Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. , 2011, European urology.

[11]  R. Pearson.  Association of Colonoscopy and Death from Colorectal Cancer , 2009 .

[12]  P. Bossuyt,et al.  Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review , 2006, The American Journal of Gastroenterology.

[13]  Thomas D. Wang,et al.  In vivo targeting of colonic dysplasia on fluorescence endoscopy with near-infrared octapeptide , 2012, Gut.

[14]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[15]  Paul Fockens,et al.  Endoscopic trimodal imaging detects colonic neoplasia as well as standard video endoscopy. , 2011, Gastroenterology.

[16]  Xiaoyuan Chen,et al.  Design and development of molecular imaging probes. , 2010, Current topics in medicinal chemistry.

[17]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[18]  T. Skotland,et al.  Whole-body section fluorescence imaging--a novel method for tissue distribution studies of fluorescent substances. , 2009, Contrast media & molecular imaging.

[19]  B. Leggett,et al.  Role of the serrated pathway in colorectal cancer pathogenesis. , 2010, Gastroenterology.

[20]  D. Hewett,et al.  Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy , 2010 .

[21]  Ralph Weissleder,et al.  Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. , 2002, Gastroenterology.

[22]  Anna M Wu,et al.  Antibodies for Molecular Imaging of Cancer , 2008, Cancer journal.

[23]  W. Domschke,et al.  Fluorescence Endoscopy Using a Fluorescein-Labeled Monoclonal Antibody Against Carcinoembryonic Antigen in Patients with Colorectal Carcinoma and Adenoma , 2002, Endoscopy.

[24]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[25]  H. Brenner,et al.  Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. , 2010, Journal of the National Cancer Institute.

[26]  Hisataka Kobayashi,et al.  Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe , 2012, Gut.

[27]  Douglas K Rex,et al.  Reducing costs of colon polyp management. , 2009, The Lancet. Oncology.

[28]  Christopher H Contag,et al.  Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. , 2008, Nature medicine.

[29]  Thomas D. Wang,et al.  Molecular imaging in gastrointestinal endoscopy. , 2010, Gastroenterology.

[30]  H. Pohl,et al.  A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect? , 2007, Gut.

[31]  今泉 克一,et al.  Dual-wavelength excitation of mucosal autofluorescence for precise detection of diminutive colonic adenomas , 2012 .

[32]  Martin Goetz,et al.  New imaging techniques and opportunities in endoscopy , 2011, Nature Reviews Gastroenterology &Hepatology.